We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$22.8B
AUM Growth
-$4.8M
Cap. Flow
+$69.6M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.53%
Holding
188
New
24
Increased
37
Reduced
34
Closed
37

Top Buys

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$580M
2
ADSK icon
Autodesk
ADSK
+$544M
3
MCK icon
McKesson
MCK
+$342M
4
TMO icon
Thermo Fisher Scientific
TMO
+$288M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$275M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$508M
2
CRM icon
Salesforce
CRM
+$266M
3
NOW icon
ServiceNow
NOW
+$264M
4
SPGI icon
S&P Global
SPGI
+$246M
5
SHW icon
Sherwin-Williams
SHW
+$212M

Sector Composition

Rank Sector Weight
1 Healthcare 33.98%
2 Technology 14.71%
3 Financials 12.17%
4 Communication Services 7.05%
5 Industrials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
26
McKesson
MCK
$100B
$348M 1.53%
+610,700
New +$342M
ANSS
27
DELISTED
Ansys
ANSS
$320M 1.4%
948,000
+60,000
+7% +$20.1M
ABNB icon
28
Airbnb
ABNB
$110B
$319M 1.4%
2,429,200
+58,000
+2% +$7.81M
NDAQ icon
29
Nasdaq
NDAQ
$54.9B
$309M 1.36%
3,998,019
+235,748
+6% +$18.2M
CBRE icon
30
CBRE Group
CBRE
$44B
$286M 1.26%
2,179,800
-790,600
-27% -$104M
LBRDK
31
DELISTED
Liberty Broadband Class C
LBRDK
$277M 1.21%
3,700,000
+3,040,000
+461% +$253M
WAB icon
32
Wabtec
WAB
$50.3B
$271M 1.19%
1,430,198
-781,200
-35% -$151M
WWD icon
33
Woodward
WWD
$20.3B
$253M 1.11%
1,521,300
+367,300
+32% +$62.7M
ADI icon
34
Analog Devices
ADI
$182B
$246M 1.08%
1,157,200
-314,900
-21% -$69.6M
SCHW
35
Charles Schwab
SCHW
$194B
$235M 1.03%
+3,169,000
New +$237M
PTGX icon
36
Protagonist Therapeutics
PTGX
$9.99B
$229M 1%
5,930,006
+69,000
+1% +$3.01M
HCP
37
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$221M 0.97%
6,453,000
+2,008,000
+45% +$68M
CRNX icon
38
Crinetics Pharmaceuticals
CRNX
$8.99B
$208M 0.91%
4,075,098
+2,913,098
+251% +$163M
BEAM icon
39
Beam Therapeutics
BEAM
$3.07B
$204M 0.9%
8,239,123
+31,000
+0.4% +$791K
HIMS icon
40
Hims & Hers Health
HIMS
$7.88B
$203M 0.89%
8,377,000
+8,364,000
+64,338% +$207M
AGIO icon
41
Agios Pharmaceuticals
AGIO
$1.98B
$186M 0.82%
5,674,466
+13,600
+0.2% +$639K
BMY icon
42
Bristol-Myers Squibb
BMY
$137B
$180M 0.79%
+3,188,000
New +$178M
YMM icon
43
Full Truck Alliance
YMM
$9.1B
$179M 0.79%
16,585,095
-4,080,453
-20% -$39.8M
V icon
44
Visa
V
$693B
$174M 0.76%
549,510
-202,500
-27% -$60.9M
BHVN icon
45
Biohaven
BHVN
$2.09B
$165M 0.73%
4,428,167
+785,578
+22% +$36.7M
JNPR
46
DELISTED
Juniper Networks
JNPR
$158M 0.69%
4,225,000
+2,940,000
+229% +$111M
MA icon
47
Mastercard
MA
$509B
$156M 0.68%
295,671
-211,000
-42% -$109M
EDU icon
48
New Oriental
EDU
$8.88B
$151M 0.66%
2,359,150
-174,450
-7% -$11.2M
X
49
DELISTED
US Steel
X
$128M 0.56%
3,776,000
+1,371,000
+57% +$50.6M
BBIO icon
50
BridgeBio Pharma
BBIO
$15.9B
$115M 0.51%
4,195,000
+2,448,000
+140% +$63.3M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2024 Portfolio in Review

As of Q4 2024, Thomas Steyer held 188 positions worth $22.8B, down 0.02% from $22.8B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Thomas Steyer's Q4 2024 filing shows 24 new, 37 increased, 34 reduced and 37 closed positions. Its largest new stake was Autodesk: 1,841,800 shares worth $544M. The largest sale was CATALENT, INC., an estimated $508M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q4 2024 buy was Autodesk: 1,841,800 shares worth $544M.
  • Thomas Steyer added most to Discover Financial Services in Q4 2024, an estimated $580M increase.
  • Thomas Steyer's biggest Q4 2024 reduction was Salesforce, cutting an estimated $266M.
  • Thomas Steyer fully exited CATALENT, INC. in Q4 2024, selling an estimated $508M.
  • Thomas Steyer's ten largest holdings make up 40% of its $22.8B portfolio in Q4 2024.
  • Thomas Steyer opened 24 new positions and closed 37 in Q4 2024.
  • Thomas Steyer's portfolio value fell 0.02% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.